Best Artificial Intelligence Stocks Worth Watching – March 22nd

InterDigital, SentinelOne, and Tempus AI are the three Artificial Intelligence stocks to watch today, according to MarketBeat’s stock screener tool. “Artificial intelligence stocks” are shares of companies whose core business is developing AI technologies (such as machine-learning software, AI chips, or cloud AI services) or whose revenue and growth are materially driven by AI products and deployment. Investors buy these equities to gain exposure to the expected long-term growth from AI adoption, while accepting higher valuation premiums, rapid technological risk, and often greater volatility. These companies had the highest dollar trading volume of any Artificial Intelligence stocks within the last several days.

InterDigital (IDCC)

InterDigital, Inc. operates as a global research and development company with focus primarily on wireless, visual, artificial intelligence (AI), and related technologies. The company engages in the design and development of technologies that enable connected in a range of communications and entertainment products and services, which are licensed to companies providing such products and services, including makers of wireless communications, consumer electronics, IoT devices, and cars and other motor vehicles, as well as providers of cloud-based services, such as video streaming.

SentinelOne (S)

SentinelOne, Inc. operates as a cybersecurity provider in the United States and internationally. Its Singularity Platform delivers an artificial intelligence-powered autonomous threat prevention, detection, and response capabilities across an organization's endpoints, cloud workloads, and identify credentials, which enables seamless and autonomous protection against a spectrum of cyber threats.

Tempus AI (TEM)

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.